GJB5 and pancreatic neoplasm: The higher expression of GJB5 (Gap Junction β5, a member of the β-type connexin family) is considered a predictor of poor clinical outcomes in pancreatic cancer patients; however, the information about its contribution in pancreatic cancer pathogenesis is scarce [66].